SCHEMBL8240402

SCHEMBL8240402

COCCCOC(=O)Nc1ccc(C)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.56
RAB9A P51151 8/20 0.56
CASP1 P29466 1/20 0.56
PKM P14618 1/20 0.56
SMN1; SMN2 Q16637 9/20 0.52
ALDH1A1 P00352 4/20 0.52
HPGD P15428 3/20 0.52
MAPK1 P28482 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MAPT P10636 1/20 0.52
MCL1 Q07820 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
LMNA P02545 2/20 0.51
RECQL P46063 2/20 0.50
HSD17B10 Q99714 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
POLB P06746 1/20 0.49
TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8238907 0.90 PKM (0.58) NPC1RAB9ACASP1PKMSMN1; SMN2
SCHEMBL19011398 0.90 SMN1; SMN2 (0.58) NPC1RAB9ACASP1PKMSMN1; SMN2
SCHEMBL12994652 0.86 PKM (0.54) NPC1RAB9ACASP1PKMSMN1; SMN2
SCHEMBL10192215 0.85 RAB9A (0.70) NPC1RAB9ACASP1SMN1; SMN2ALDH1A1
SCHEMBL4843520 0.85 RAB9A (0.67) NPC1RAB9ACASP1SMN1; SMN2ALDH1A1
SCHEMBL2056347 0.84 RAB9A (0.61) NPC1RAB9ACASP1SMN1; SMN2ALDH1A1
SCHEMBL10192025 0.84 SMN1; SMN2 (0.52) NPC1RAB9ACASP1PKMSMN1; SMN2
SCHEMBL21059194 0.84 RAB9A (0.64) NPC1RAB9ACASP1PKMSMN1; SMN2
SCHEMBL2054645 0.83 SMN1; SMN2 (0.56) NPC1RAB9ACASP1SMN1; SMN2ALDH1A1
SCHEMBL27770547 0.83 RAB9A (0.55) NPC1RAB9ACASP1PKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007070826-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO disclosed